Table 1.
CYP | PDB ID | Environmentb | Ligandc | Ensembled | Time (ns) |
---|---|---|---|---|---|
CYP51 (T. brucei) | 3G1Q | SOL | ------ | NPT | 30 |
3G1Q | MEM | ------ | NPγT | 60 | |
3P99e | SOL | MCP | NPT | 30 | |
3P99e | MEM | MCP | NPγT | 15 | |
CYP51 (human) | 3LD6 | SOL | ------ | NPT | 15 |
CYP2C9_M1 (human)a | 1R9O | SOL | ------ | NPT | 28.28 |
1R9O | MEM | ------ | NPγT | 18.75 | |
1R9O | SOL | FLO | NPT | 27.84 | |
1R9O | MEM | FLO | NPγT | 11.25 | |
CYP2C9_M2 (human)a | 1R9O | SOL | ------ | NPT | 27.78 |
1R9O | MEM | ------ | NPγT | 18.75 | |
1R9O | SOL | FLO | NPT | 27.4 | |
1R9O | MEM | FLO | NPγT | 11.25 | |
CYP2E1 (human) | 3KOH | SOL | ------ | NPT | 10 |
3T3Z | SOL | ------ | NPT | 10 |
The F-G loop region in the crystal structure of human CYP2C9 (PDB id: 1R9O) is missing. Two models of the F-G loop were generated for the simulations (Cojocaru et al., 2011). Model 1 has F′ and G′ helices, and model 2 has an unstructured F-G loop.
SOL, the soluble CYPs (no membrane); MEM, the membrane-bound CYPs in a lipid bilayer.
The ligands used in the simulation. FLO, 4′-hydroxy flurbiprofen; MCP, 14α-methylenecyclopropyl-Δ7-24,25-dihydrolanosterol; “----”, ligand-free structures.
In the NPγT simulations of the membrane-bound CYPs, a surface tension, γ = 60 dyn/cm, was applied to the plane of the membrane together with the pressure control to maintain the bilayer dynamics (Cojocaru et al., 2011). A comparison of the area per lipid, the bilayer thickness, and the order parameters of the membrane in the 60-ns simulation of the membrane-bound CYP51 with experimental data is plotted in Figures S6 and S7.
Only the ligand MCP of 3P99 was transferred into the active site of the equilibrated ligand-free CYP51 structure (originally derived from the crystal structure 3G1Q). The simulations were then performed starting with this structure (see Methods).